IFNG and myeloid sarcoma: We next performed a mixed T cell ELISpot assay and demonstrated that IFN-g T cell responses were decreased when T cells from three separate donors were cultured with SLCLs obtained from an MS patient in the active phase of their disease (Fig. 6E).